Idecabtagene vicleucel (ide-cel) versus standard regimens (SRs) in triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3 sub-analysis of black patients Meeting Abstract
| Authors: | Patel, K. K.; Rodríguez-Otero, P.; Nooka, A. K.; Callander, N. S.; Solomon, S. R.; Baz, R.; Sborov, D. W.; Gergis, U.; Badros, A. Z.; Giralt, S. A.; Pearse, R.; Abonour, R.; Siegel, D. S.; Larson, S. M.; Munshi, N. C.; Truppel-Hartmann, A.; Bhatnagar, R.; Wu, F.; Piasecki, J.; Felten, J.; Caia, A.; Cook, M.; Popa, M.; Jagannath, S.; Ailawadhi, S. |
| Abstract Title: | Idecabtagene vicleucel (ide-cel) versus standard regimens (SRs) in triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3 sub-analysis of black patients |
| Meeting Title: | 12th Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) |
| Keywords: | multiple myeloma; safety; progression-free survival; phase 3; mm; car t cell therapy; triple-class exposed |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 24 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Sep 4-7 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | S551 |
| End Page: | S552 |
| Language: | English |
| ACCESSION: | WOS:001315579605109 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(24)01671-9 |
| Notes: | Meeting Abstract: MM-359 -- Source: Wos |
